Derek Wheeler began a career in analytical chemistry, product formulation, process engineering, marketing and general management for a number of major cosmetic and pharmaceutical manufactures. He founded Disperse Ltd. to develop and exploit patents on the PAD™ Technology. Derek was part of a subsequent management and PAD™ Technology buyout from Disperse Ltd. forming the basis of MC2 Therapeutics Derek enjoys an international reputation as a leading dispersion scientist and is a member of the Society of Cosmetic Scientists where he is an examination question setter and marker. He has been called as an expert witness and has widely written and lectured on dispersion issues and is the author of a number of patents.
Ophthalmology